MedPath

Study of the Effects of High Dose Aflibercept Injected Into the Eye of Patients With an Age-related Disorder That Causes Loss of Vision Due to Growth of Abnormal Blood Vessels at the Back of the Eye

Phase 3
Active, not recruiting
Conditions
Neovascular Age-Related Macular Degeneration
Interventions
Registration Number
NCT04423718
Lead Sponsor
Bayer
Brief Summary

In this study researchers want to learn more about changes in visual acuity (clarity of vision) with a high dose treatment with Aflibercept (Eylea) in patients suffering from neovascular age-related macular degeneration (nAMD). Neovascular AMD is an eye disease that causes blurred vision or a blind spot due to abnormal blood vessels that leak fluid or blood into the light sensitive lining inside the eye (retina). The fluid buildup causes the central part of the retina (macula) responsible for sharp, straight-ahead vision to swell and thicken (edema), which distorts vision.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
1011
Inclusion Criteria
  • Active subfoveal CNV secondary to nAMD, including juxtafoveal lesions that affect the fovea as assessed in the study eye.
  • Total area of CNV (including both classic and occult components) must comprise greater than 50% of the total lesion area in the study eye.
  • BCVA ETDRS letter score of 78 to 24 (corresponding to a Snellen equivalent of approximately 20/32 to 20/320) in the study eye.
  • Decrease in BCVA determined to be primarily the result of nAMD in the study eye.
  • Presence of IRF and/or SRF affecting the central subfield of the study eye on OCT.
  • Contraceptive use by men or women should be consistent with local regulations regarding the methods of highly effective contraception for those participating in clinical studies.
  • Other protocol-specified inclusion criteria.

Additional inclusion criteria for Year 3:

  • At least one BCVA value and one central subfield retinal thickness (CST) value from measurements at one of the following visits: Visit 24 (Week 84), Visit 25 (Week 88) or Visit 26 (Week 92).
  • Participant is enrolled at a site that participates in the extension period.
Exclusion Criteria
  • Causes of CNV other than nAMD in the study eye.
  • Scar, fibrosis, or atrophy involving the central subfield in the study eye.
  • Presence of retinal pigment epithelial tears or rips involving the central subfield in the study eye.
  • Uncontrolled glaucoma (defined as IOP >25 mmHg despite treatment with anti-glaucoma medication) in the study eye.
  • History of idiopathic or autoimmune uveitis in the study eye.
  • Myopia of a spherical equivalent of at least 8 diopters in the study eye prior to any refractive or cataract surgery.
  • History or clinical evidence of diabetic retinopathy, diabetic macular edema, or any retinal vascular disease other than nAMD in either eye.
  • Evidence of extraocular or periocular infection or inflammation (including infectious blepharitis, keratitis, scleritis, or conjunctivitis) in either eye at the time of screening/randomization.
  • Uncontrolled blood pressure (defined as systolic >160 mmHg or diastolic >95 mmHg).
  • Any prior or concomitant ocular (in the study eye) or systemic treatment (with an investigational or approved, anti-VEGF or other agent) or surgery for nAMD, except dietary supplements or vitamins.
  • Other protocol-specified exclusion criteria

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Aflibercept 2q8Aflibercept High Dose VEGF Trap-Eye (BAY86-5321)In the double-masked study part (Years 1 and 2), Aflibercept 2 mg administered every 8 weeks after a loading phase. (Active Comparator) In Year 3, high dose aflibercept administered according to individual patient response. (Experimental)
Aflibercept 2q8Aflibercept VEGF Trap-Eye (Eylea, BAY86-5321)In the double-masked study part (Years 1 and 2), Aflibercept 2 mg administered every 8 weeks after a loading phase. (Active Comparator) In Year 3, high dose aflibercept administered according to individual patient response. (Experimental)
Aflibercept HDq12Aflibercept High Dose VEGF Trap-Eye (BAY86-5321)Aflibercept high dose (HD) administered every 12 weeks after an initiation phase. Treatment intervals adjusted according to individual patient response.
Aflibercept HDq16Aflibercept High Dose VEGF Trap-Eye (BAY86-5321)Aflibercept high dose administered every 16 weeks after an initiation phase. Treatment intervals adjusted according to individual patient response.
Primary Outcome Measures
NameTimeMethod
Change From Baseline in BCVA Measured by the ETDRS Letter Score at Week 48At baseline and Week 48

Visual function of the study eye was assessed at a distance of 4 meters using the ETDRS BCVA letter score. BCVA scale range is 0 (worst) to 100 (best).

Secondary Outcome Measures
NameTimeMethod
Percentage of Participants With no Intraretinal Fluid (IRF) and no Subretinal Fluid (SRF) in Central Subfield at Week 16At Week 16
Percentage of Participants With no Intraretinal Fluid (IRF) and no Subretinal Fluid (SRF) in the Center Subfield at Week 48At Week 48
Percentage of Participants Achieving an ETDRS Letter Score of at Least 69 (Approximate 20/40 Snellen Equivalent) at Week 48At Week 48
Change in Total Lesion Area From Baseline to Week 48At baseline and Week 48
Change From Baseline in Central Subfield Retinal Thickness (CST) at Week 48At baseline and Week 48
Change From Baseline in BCVA Measured by the ETDRS Letter Score at Week 60At baseline and Week 60

Visual function of the study eye was assessed at a distance of 4 meters using the ETDRS BCVA letter score. BCVA scale range is 0 (worst) to 100 (best).

Number of Participants With Treatment-emergent Adverse Events (TEAEs) and Serious AEs (SAEs)Up to 156 weeks
Percentage of Participants Gaining at Least 15 Letters in BCVA From Baseline at Week 48At baseline and Week 48
Change in Choroidal Neovascularization (CNV) Size From Baseline to Week 48At baseline and Week 48
Change From Baseline in National Eye Institute Visual Functioning Questionnaire-25 (NEI-VFQ-25) Total Score at Week 48At baseline and Week 48

NEI VFQ-25 was a 25-item questionnaire that gave a score on a scale from 0 (worst) to 100 (best = no vision problems)

Systemic Exposure to Aflibercept as Assessed by Plasma Concentrations of Free, Adjusted Bound and Total Aflibercept From Baseline Through Week 48Up to Week 48
Assessment of Immunogenicity to Aflibercept by Measuring the Incidence of Treatment-emergent Anti-drug Antibodies (ADA) Response Through End of Masked StudyUp to week 96

Trial Locations

Locations (235)

SEHAT Pentagram

🇧🇬

Sofia, Bulgaria

University Multiprofile Hospital For Active Treatment 'Alexandrovska' EAD

🇧🇬

Sofia, Bulgaria

Arizona Retina and Vitreous Consultants - North Phoenix

🇺🇸

Phoenix, Arizona, United States

Retina Consultants of Orange County

🇺🇸

Fullerton, California, United States

University of California San Diego (UCSD)

🇺🇸

La Jolla, California, United States

Northern California Retina-Vitreous Associates

🇺🇸

Mountain View, California, United States

California Eye Specialists Medical Group, Inc.

🇺🇸

Pasadena, California, United States

Retina Consultants San Diego

🇺🇸

Poway, California, United States

Retina Consultants of Southern California

🇺🇸

Redlands, California, United States

Kaiser Permanente Riverside Medical Center

🇺🇸

Riverside, California, United States

Retina Consultants of Southern Colorado, PC

🇺🇸

Colorado Springs, Colorado, United States

New England Retina Associates

🇺🇸

New London, Connecticut, United States

Rand Eye Institute

🇺🇸

Deerfield Beach, Florida, United States

Retina Group of Florida - Fort Lauderdale

🇺🇸

Fort Lauderdale, Florida, United States

Vitreo Retinal Associates PA - The Millennium Center Location

🇺🇸

Gainesville, Florida, United States

Florida Retina Institute- Jacksonville Oak

🇺🇸

Jacksonville, Florida, United States

Florida Eye Associates

🇺🇸

Melbourne, Florida, United States

Retina Macula Specialists Of Miami

🇺🇸

Miami, Florida, United States

Florida Retina Institute

🇺🇸

Orlando, Florida, United States

Spec. Hosp. for Active Treatment for Eye Diseases Zrenie

🇧🇬

Sofia, Bulgaria

Retina Specialists

🇺🇸

Pensacola, Florida, United States

Retina Vitreous Associates of Florida - Saint Petersburg

🇺🇸

Saint Petersburg, Florida, United States

Southern Vitreoretinal Associates, P.L. - Tallahassee

🇺🇸

Tallahassee, Florida, United States

Retina Consultants of Hawaii

🇺🇸

'Aiea, Hawaii, United States

Retina Associates IL

🇺🇸

Elmhurst, Illinois, United States

University Retina and Macula Associates

🇺🇸

Oak Forest, Illinois, United States

Wolfe Eye Clinic - Des Moines

🇺🇸

West Des Moines, Iowa, United States

Retina Care Center

🇺🇸

Baltimore, Maryland, United States

Ophthalmic Consultants of Boston (OCB) - Boston

🇺🇸

Boston, Massachusetts, United States

Vitreo Retinal Surgery PA - Edina

🇺🇸

Edina, Minnesota, United States

Retina Consultants of Nevada

🇺🇸

Las Vegas, Nevada, United States

Retina Center of New Jersey

🇺🇸

Bloomfield, New Jersey, United States

NJ Retina - Edison Office

🇺🇸

Edison, New Jersey, United States

Eye Associates of New Mexico

🇺🇸

Albuquerque, New Mexico, United States

Long Island Vitreoretinal Consultants

🇺🇸

Great Neck, New York, United States

Long Island Vitreoretinal Consultants - Hauppauge

🇺🇸

Hauppauge, New York, United States

Ophthalmic Consultants of Long Island

🇺🇸

Lynbrook, New York, United States

Ophthalmic Consultants of the Capital Region

🇺🇸

Troy, New York, United States

Wake Forest Baptist Health

🇺🇸

Winston-Salem, North Carolina, United States

Midwest Retina - Main Office

🇺🇸

Dublin, Ohio, United States

Retina Northwest, PC - Opthalmology

🇺🇸

Portland, Oregon, United States

Retina Consultants, LLC

🇺🇸

Salem, Oregon, United States

Mid Atlantic Retina

🇺🇸

Bethlehem, Pennsylvania, United States

Erie Retinal Surgery, Inc.

🇺🇸

Erie, Pennsylvania, United States

Eye Care Specialists

🇺🇸

Kingston, Pennsylvania, United States

Charleston Neuroscience Institute - Charleston

🇺🇸

Charleston, South Carolina, United States

Palmetto Retina Center (PRC)- West Columbia Retina Center

🇺🇸

West Columbia, South Carolina, United States

Black Hills Regional Eye Institute

🇺🇸

Rapid City, South Dakota, United States

Charles Retina Institute

🇺🇸

Memphis, Tennessee, United States

Vanderbilt University Medical School

🇺🇸

Nashville, Tennessee, United States

Austin Retina Associates

🇺🇸

Austin, Texas, United States

Texas Retina Associates

🇺🇸

Fort Worth, Texas, United States

Medical Center Ophthalmology Associates

🇺🇸

San Antonio, Texas, United States

Retinal Consultants of Texas - San Antonio

🇺🇸

San Antonio, Texas, United States

Retina Consultants of Texas (Retina Consultants of Houston) - Texas Medical Center

🇺🇸

The Woodlands, Texas, United States

Retina Consultants of Texas - The Woodlands

🇺🇸

The Woodlands, Texas, United States

The University of Vermont Medical Center (Fletcher Allen Health Care) - Main Campus

🇺🇸

Burlington, Vermont, United States

Spokane Eye Clinical Research

🇺🇸

Spokane, Washington, United States

West Virginia University

🇺🇸

Morgantown, West Virginia, United States

University of Wisconsin - Madison

🇺🇸

Madison, Wisconsin, United States

Organizacion Medica de Investigacion (OMI)

🇦🇷

Buenos Aires, Ciudad Auton. De Buenos Aires, Argentina

OFTALMOS, Instituto Oftalmologico de Alta Complejidad

🇦🇷

Buenos Aires, Ciudad Auton. De Buenos Aires, Argentina

Eyeclinic Albury Wodonga

🇦🇺

Albury, New South Wales, Australia

Sydney Retina Clinic

🇦🇺

Sydney, New South Wales, Australia

Westmead Hospital

🇦🇺

Westmead, New South Wales, Australia

Hobart Eye Surgeons

🇦🇺

Hobart, Tasmania, Australia

Marsden Eye Surgery Center

🇦🇺

Parramatta, Australia

Klinikum Klagenfurt am Wörthersee

🇦🇹

Klagenfurt, Kärnten, Austria

Kepler Universitätsklinikum Campus III

🇦🇹

Linz, Oberösterreich, Austria

Konventhospital Barmherzige Brüder Linz

🇦🇹

Linz, Oberösterreich, Austria

Medizinische Universität Graz

🇦🇹

Graz, Steiermark, Austria

Hanusch-Krankenhaus Wien

🇦🇹

Wien, Austria

Multiprofile Hospital for Active Treatment Sveta Sofia | Internal Diseases Department

🇧🇬

Sofia, Bulgaria

Specialized Hospital For Active Treatment of Eye Diseases Zora

🇧🇬

Sofia, Bulgaria

Sveta Petka Eye Hospital

🇧🇬

Varna, Bulgaria

St.Joseph's Health Care-London

🇨🇦

London, Ontario, Canada

Toronto Retina Institute

🇨🇦

Toronto, Ontario, Canada

Institut de l'Oeil des Laurentides

🇨🇦

Boisbriand, Quebec, Canada

The Second Hospital of Anhui medical university

🇨🇳

Hefei, Anhui, China

Beijing Tongren Hospital, Capital Medical University (East)

🇨🇳

Beijing, Dongcheng District, China

The 1st Affiliated Hospital Fujian Medical University

🇨🇳

Fuzhou, Fujian, China

Guangzhou Aier Eye Hospital

🇨🇳

Guangzhou, Guangdong, China

Hebei eye hospital

🇨🇳

Hebei, Hebei, China

Shijiazhuang General Hospital

🇨🇳

Shijiazhuang, Hebei, China

Henan Provincial Eye Hospital

🇨🇳

Henan, Henan, China

Tongji Hosp. of Tongji Med Coll, Huazhong Uni of Sci & Tech.

🇨🇳

Wuhan, Hubei, China

Union Hospt Tongji Medical Colleg. Huazhong univ. Scien&Tech

🇨🇳

Wuhan, Hubei, China

The First People's Hospital of Xuzhou

🇨🇳

Xuzhou, Jiangsu, China

Jiangxi Provincial People's Hospital

🇨🇳

Nanchang, Jiangxi, China

The First Affiliated Hospital of NanChang University

🇨🇳

Nanchang, Jiangxi, China

Eye Center of the second Bethune Hospital, jinlin University

🇨🇳

Changchun, Jilin, China

Tonghua Central Hospital

🇨🇳

Tonghua, Jilin, China

Shenyang He Eye Specialist Hospital

🇨🇳

Shenyang, Liaoning, China

People's Hospital of Ningxia Hui Autonomous Region - Opthalmology

🇨🇳

Ningxia, Ningxia, China

The First Affiliated Hospital of Xi'an Jiaotong University

🇨🇳

Xi'an, Shanxi, China

Aier Eye Hospital (Chengdu)

🇨🇳

Chengdu, Sichuan, China

The First Affiliated Hospital of Xinjiang Medical University

🇨🇳

Urumqi, Xinjiang, China

The 1st Affiliated Hospital of Zhejiang University

🇨🇳

Hangzhou, Zhejiang, China

ZheJiang Provincial People's Hospital

🇨🇳

Hangzhou, Zhejiang, China

Clinical hospital center Zvezdara

🇷🇸

Belgrade, Serbia

The Affiliated Eye Hospital of Wenzhou Medical College

🇨🇳

Wenzhou, Zhejiang, China

Beijing Aier Intech Eye Hospital

🇨🇳

Beijing, China

Peking University People's Hospital

🇨🇳

Beijing, China

Beijing Hospital

🇨🇳

Beijing, China

Chongqing Aier Ophthalmology Hospital

🇨🇳

Chongqing, China

Shanghai Tongji Hospital of Tongji University

🇨🇳

Shanghai, China

Shanghai General Hospital

🇨🇳

Shanghai, China

Tianjin Medical University General Hospital

🇨🇳

Tianjin, China

Tianjin Eye Hospital

🇨🇳

Tianjin, China

Tianjin Medical University Eye Hospital

🇨🇳

Tianjin, China

Fakultni Nemocnice Hradec Kralove

🇨🇿

Hradec Kralove, Czechia

Fakultni nemocnice Ostrava

🇨🇿

Ostrava, Czechia

Fakultni nemocnice Plzen - Lochotin

🇨🇿

Plzen-Lochotin, Czechia

Charles University in Prague

🇨🇿

Prague, Czechia

Fakultni nemocnice Kralovske Vinohrady

🇨🇿

Praha 10, Czechia

Lexum a.s., Evropska ocni klinika

🇨🇿

Praha 4, Czechia

AXON Clinical s.r.o.

🇨🇿

Praha 5, Czechia

East Tallinn Central Hospital

🇪🇪

Tallinn, Estonia

Tartu University Hospital

🇪🇪

Tartu, Estonia

Centre d'Ophtalmologie - Paradis-Monticelli

🇫🇷

Marseille, France

Hôpital Lariboisière - Paris

🇫🇷

Paris, France

Centre ophtalmologique Saint-Exupéry

🇫🇷

Saint-Cyr-Sur-Loire, France

LTD "Clinic LJ" - Opthalmology

🇬🇪

Kutaisi, Georgia

JSC "Evex Hospitals'

🇬🇪

Tbilisi, Georgia

LTD "Innova"

🇬🇪

Tbilisi, Georgia

LTD "Chichua Medical Center MZERA"

🇬🇪

Tbilisi, Georgia

Budapest Retina Associates

🇭🇺

Budapest, Hungary

Szent-Gyorgyi Albert Orvostudomanyi Egyetem

🇭🇺

Szeged, Hungary

Rambam Health Corporation

🇮🇱

Haifa, Israel

Lady Davis Carmel Medical Center

🇮🇱

Haifa, Israel

Hadassah Hebrew University Hospital Ein Kerem

🇮🇱

Jerusalem, Israel

Meir Medical Center

🇮🇱

Kfar Saba, Israel

Chaim Sheba Medical Center

🇮🇱

Ramat Gan, Israel

Kaplan Medical Center

🇮🇱

Rehovot, Israel

Assuta Medical Centers - HaShalom

🇮🇱

Tel Aviv, Israel

Fondazione PTV Policlinico Tor Vergata

🇮🇹

Roma, Lazio, Italy

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

🇮🇹

Roma, Lazio, Italy

IRCCS Fondazione G.B. Bietti Studio e Ricerca in Otalmologia

🇮🇹

Roma, Lazio, Italy

ASST Fatebenefratelli Sacco

🇮🇹

Milano, Lombardia, Italy

Ospedale San Raffaele s.r.l. - Oculistica

🇮🇹

Milano, Lombardia, Italy

A.O.U. di Cagliari

🇮🇹

Cagliari, Sardegna, Italy

A.O. di Perugia

🇮🇹

Perugia, Umbria, Italy

Daiyukai Daiichi Hospital

🇯🇵

Ichinomiya, Aichi, Japan

Aichi Medical University Hospital

🇯🇵

Nagakute, Aichi, Japan

Nagoya University Hospital

🇯🇵

Nagoya, Aichi, Japan

Nagoya City University Hospital

🇯🇵

Nagoya, Aichi, Japan

Kokura Memorial Hospital

🇯🇵

Kitakyushu, Fukuoka, Japan

Kurume University Hospital

🇯🇵

Kurume, Fukuoka, Japan

Southern Tohoku Eye Clinic

🇯🇵

Koriyama, Fukushima, Japan

Gunma University Hospital

🇯🇵

Maebashi, Gunma, Japan

Sapporo City General Hospital

🇯🇵

Sapporo, Hokkaido, Japan

KKR Sapporo Medical Center

🇯🇵

Sapporo, Hokkaido, Japan

Hyogo Prefectural Amagasaki General Medical Center

🇯🇵

Amagasaki, Hyogo, Japan

Kobe University Hospital

🇯🇵

Kobe, Hyogo, Japan

Kozawa Eye Hospital and Diabetes Center

🇯🇵

Mito, Ibaraki, Japan

Kanazawa Medical University Hospital

🇯🇵

Kahoku-gun, Ishikawa, Japan

Kanazawa University Hospital

🇯🇵

Kanazawa, Ishikawa, Japan

Kagawa University Hospital

🇯🇵

Kita-gun, Kagawa, Japan

Medical corporation Eiwakai Dannoue Ophthalmology clinic

🇯🇵

Kawasaki, Kanagawa, Japan

St. Marianna University Hospital

🇯🇵

Kawasaki, Kanagawa, Japan

Otakeganka Tsukimino Clinic

🇯🇵

Yamato, Kanagawa, Japan

Mie University Hospital

🇯🇵

Tsu, Mie, Japan

Shinshu University Hospital

🇯🇵

Matsumoto, Nagano, Japan

Nara Medical University Hospital

🇯🇵

Kashihara, Nara, Japan

Oita University Hospital

🇯🇵

Yufu, Oita, Japan

Kurashiki Medical Center

🇯🇵

Kurashiki, Okayama, Japan

Okayama University Hospital

🇯🇵

Okayama-city, Okayama, Japan

University of the Ryukyus Hospital

🇯🇵

Nakagami, Okinawa, Japan

Kansai Medical University Hospital

🇯🇵

Hirakata, Osaka, Japan

Kansai Medical University Medical Center

🇯🇵

Moriguchi, Osaka, Japan

Kindai University Hospital

🇯🇵

Osakasayama-shi, Osaka, Japan

The University of Tokyo Hospital

🇯🇵

Bunkyo-ku, Tokyo, Japan

St.Luke's International Hospital

🇯🇵

Chuoku, Tokyo, Japan

Nishikasai Inouye Eye Hospital

🇯🇵

Edogawa-ku, Tokyo, Japan

Tokyo Medical University Hachioji Medical Center

🇯🇵

Hachioji, Tokyo, Japan

Tokiwadai Muranaka Eye Clinic

🇯🇵

Itabashi-ku, Tokyo, Japan

National Hospital Organization Tokyo Medical Center

🇯🇵

Meguro-ku, Tokyo, Japan

Keio University Hospital

🇯🇵

Shinjuku-ku, Tokyo, Japan

Tokyo Women's Medical University Hospital

🇯🇵

Shinjuku-ku, Tokyo, Japan

Yamaguchi University Hospital

🇯🇵

Ube, Yamaguchi, Japan

University of Yamanashi Hospital

🇯🇵

Chuo, Yamanashi, Japan

Akita University Hospital

🇯🇵

Akita, Japan

Hayashi Eye Hospital

🇯🇵

Fukuoka, Japan

Klinicki centar Vojvodine

🇷🇸

Novi Sad, Serbia

Fukushima Medical University Hospital

🇯🇵

Fukushima, Japan

Hiroshima University Hospital

🇯🇵

Hiroshima, Japan

University of Miyazaki Hospital

🇯🇵

Miyazaki, Japan

Japanese Red Cross Nagasaki Genbaku Hospital

🇯🇵

Nagasaki, Japan

Japanese Red Cross Saitama Hospital

🇯🇵

Saitama, Japan

Tokushima University Hospital

🇯🇵

Tokushima, Japan

Japanese Red Cross Wakayama Medical center

🇯🇵

Wakayama, Japan

Yamagata University Hospital

🇯🇵

Yamagata, Japan

Nune Eye Hospital - Retina Center Ophthalmology

🇰🇷

Seoul, Gangnam-gu, Korea, Republic of

Seoul National University Bundang Hospital

🇰🇷

Seongnam-si, Gyeonggido, Korea, Republic of

Pusan National University Hospital

🇰🇷

Busan, Korea, Republic of

Inje University Haeundae Paik Hospital

🇰🇷

Busan, Korea, Republic of

Seoul National University Hospital (b)

🇰🇷

Seoul, Korea, Republic of

Asan Medical Center

🇰🇷

Seoul, Korea, Republic of

Samsung Medical Center

🇰🇷

Seoul, Korea, Republic of

Department of Ophthalmology

🇱🇻

Riga, Latvia

Latvian American Eye Center

🇱🇻

Riga, Latvia

Riga East Clinical University Hospital "Gailezers"

🇱🇻

Riga, Latvia

Hospital of LT University of Health Sciences Kaunas Clinics

🇱🇹

Kaunas, Lithuania

PI Klaipedos University Hospital

🇱🇹

Klaipeda, Lithuania

Vilnius University Hospital Santaros Klinikos

🇱🇹

Vilnius, Lithuania

ALM Oftalmolaser - Oftalmologia Medica e Cirurgica

🇵🇹

Lisbon, Lisboa, Portugal

AIBILI

🇵🇹

Coimbra, Portugal

Espaco Medico de Coimbra

🇵🇹

Coimbra, Portugal

Centro Hospitalar Universitario do Porto

🇵🇹

Porto, Portugal

Centro Hospitalar Vila Nova de Gaia e Espinho | Unit 1 - Clinical Research Center

🇵🇹

Porto, Portugal

Scientific Research Institution of Ophthalmic Diseases

🇷🇺

Moscow, Russian Federation

FBSI IRTC Eye Microsurgery n.a. acad. S.N. Fyodorov

🇷🇺

Moscow, Russian Federation

Clinical Center of Serbia

🇷🇸

Belgrade, Serbia

National University Hospital

🇸🇬

Singapore, Singapore

Singapore National Eye Centre

🇸🇬

Singapore, Singapore

Fakultna nemocnica Nitra

🇸🇰

Nitra, Slovakia

Nemocnica s Poliklinikou Trebisov, Svet zdravia a.s.

🇸🇰

Trebisov, Slovakia

Fakultna nemocnica Trencin

🇸🇰

Trencin, Slovakia

Fakultna nemocnica s poliklinikou Zilina

🇸🇰

Zilina, Slovakia

Instituto Oftalmológico Francisco Gomez Ulla

🇪🇸

Santiago de Compostela, A Coruña, Spain

Hospital Clínic i Provincial de Barcelona

🇪🇸

Barcelona, Spain

Hospital de la Santa Creu i Sant Pau | Gynecology Department

🇪🇸

Barcelona, Spain

Hospital Reina Sofía

🇪🇸

Córdoba, Spain

Hospital General Universitario de Valencia

🇪🇸

Valencia, Spain

La Fe University and Polytechnic Hospital | Nephrology Department

🇪🇸

Valencia, Spain

Hospital Miguel Servet

🇪🇸

Zaragoza, Spain

RétinElysée

🇨🇭

Lausanne, Vaud, Switzerland

Berner Augenklinik am Lindenhofspital

🇨🇭

Bern, Switzerland

Stadtspital Triemli

🇨🇭

Zürich, Switzerland

Shin Kong Wu Ho-Su Memorial Hospital

🇨🇳

Taipei, Taiwan

Taipei Veterans General Hospital

🇨🇳

Taipei, Taiwan

Chang Gung Memorial Hospital at Linkou

🇨🇳

Taoyuan, Taiwan

Private enterprise private production company " Acinus"

🇺🇦

Kropyvnytskyi, Ukraine

Centralna Polyclinica MVS Ukraiiny

🇺🇦

Kyiv, Ukraine

Poltava Regional Clinical Hospital n.a. M.V. Skliphosovskyi

🇺🇦

Poltava, Ukraine

© Copyright 2025. All Rights Reserved by MedPath